Read article – Quotes Daniel R. Lucey, a clinical professor of medicine, in an article about an outbreak of hepatitis among children in the U.S. “One potential important clue that has not been reported yet is the pathology of the liver (from patients in Europe). The 17 liver transplant cases across several countries means that a detailed analysis of the microscopic histopathology of the liver in these cases is available,” Lucey said.

Watch video – Creator of coronavirus vaccine technology Jason McLellan, a former faculty member at the Geisel School of Medicine, will be honored by Dartmouth for his groundbreaking research that laid the foundation for the COVID-19 vaccine. McLellan has been named the recipient of Dartmouth’s inaugural “McGuire Family Prize for Societal Impact” and will receive $100,000. (Picked up by MSN.)

Read article – Continued coverage of the co-authored study by Steven Woloshin, a professor of The Dartmouth Institute and of medicine, about the usability of at-home COVID tests. The study showed that the confusing guidance included in at-home testing kits was worse than no advice at all. (Picked up by West Central Tribune.)

Read article – Features comments by Rebecca Smith, Geisel ’17, Guarini ’17 and ’26; and Anna N. A. Tosteson, the interim director and professor of The Dartmouth Institute, professor of medicine and of community and family medicine, and the James J. Carroll 1948 Professor of Oncology, in an article about their co-authored study. The study looked into patients’ breast density knowledge and breast density’s impact on future screening intentions.

Read article – Quotes Bruce Voorman, an associate professor of anesthesiology, in an article about treatments for people with chronic pain. “When it comes to treating some patients with complex chronic pain, low-dose naltrexone appears to be more effective and well-tolerated than the big-name opioids that dominated pain management for decades,” Voorman said.

Read article – Features comments by Marcus Shaker, a professor of pediatrics and medicine, in an article about barriers to epinephrine use and potentially new needle-free epinephrine products for people with anaphylaxis. Currently, epinephrine is the only effective treatment for those with anaphylaxis. “If you’re monitoring at home, it’s really important to make sure you have access to help and to emergency services and additional epinephrine if you need it,” Shaker said.

Read article – Senior scientist Pinar Gurel, Guarini ’14, Geisel ’15, is quoted in an article advising PhD students on how to navigate the situation if their supervisor were to leave their institution. “Don’t think one option is going to be detrimental to your career over another,” Gurel said.

Read article – Features the co-authored study by Steven Woloshin, professor of The Dartmouth Institute and of medicine, about the usability of at-home COVID tests. The study showed that the confusing guidance included in at-home testing kits was worse than no advice at all. The guidance did not inform people on how to act based on their results. (Picked up by The Washington Post.)

Read article – Features comments by Deborah Hogan, a professor of microbiology and immunology, in an article about new diagnostics that are helping clinicians identify fungal infections. “Clinicians need to consider more than one isolate, or perhaps whole populations, when thinking about drug therapies for particularly chronic infections,” Hogan said.